Biggest News Aggregation in the World
📰 Ciences News

Page 137 - Ciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.

BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm

HENDERSON, NV, Sept. 26, 2022 -- via NewMediaWire – BioLife Sciences is pleased to announce that it has entered into negotiations with Canadian Firm--Work In Motion towards the development... | September 26, 2022
Biolife Mfusion Biolife Sciences Inc Biolife Sciences Globenewswire Inc Life Sciences Canadian Firm Work In Motion

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug
Irina Koffler Matthew Davis Hana Malik Tiziana Life Sciences Lifesci Advisors Tiziana Life Sciences Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Quotient Sciences Global News: Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics Programs

Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities NOTTINGHAM, England, Sept. 22, 2022 /PRNewswire/ -- Quotient Sciences
United Kingdom Kostenloser Wertpapierhandel Mark Egerton Company Nottingham Prnewswire Quotient Sciences Drug Administration

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

HUNTSVILLE, Ala., Sept. 20, 2022 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, has entered into an agreement with Olink Holding AB (publ) (Olink)
United States Uppsala Lan Michael Pisano Discovery Life Sciences Prnewswire Discovery Life Sciences Research Use Only

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab

The second Expanded Access patient (EA2) demonstrated improved walking as measured by gait stability and enduranceThe patient showed clinically significant improvement in the Expanded Disability Status
Irina Koffler Hana Malik Howardl Weiner Gabriele Cerrone Tanuja Chitnis Tiziana Life Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science